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3 Abstract 
4 
5 
Objective 
7 
8 To report a case of a man who developed bilateral Charcot neuroarthropathic feet 11 
9 
10 years after a simultaneous pancreas kidney (SPK) transplantation for type 1 diabetes 
11 
12 
following which he had remained normoglycaemic 
14 
15 
16 
17 Methods 
18 
19 Retrospective review of case notes and serial imaging 
20 
21 
22 
23 
24 Results 
25 
26 We describe the case of a man who had developed dense peripheral diabetic 
27 
28 
neuropathy due to poor glycaemic control. His biochemical markers of diabetes all 
30 
31 normalised following SPK transplantation, and he was discharged by his primary and 
32 
33 secondary care diabetes services. 11 years later he developed Charcot neuropathy 
34 
35 
in one foot and within a month, the other foot as well. 
37 
38 
39 
40 Conclusion 
41 
42 Individuals with diabetes who had pre-operative end organ diabetes related damage 
43 
44 
45 who biochemically into remission after SPK transplantation should never be 
46 
47 discharged from specialist diabetes services and need continued education about 
48 
49 foot care 
50 
51 
52 
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54 Keywords: Diabetes; Charcot neuroarthopathy; simultaneous kidney pancreas 
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CN – Charcot neuroarthopathy 
7 
HbA1c - glycated haemoglobin 
9 
10 MR – Magnetic resonance 
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12 SPK - Simultaneous pancreas kidney 
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1 
2 
3 Introduction 
4 
5 
6 
7 
8 Charcot neuroarthopathy (CN) is an uncommon but devastating complication that 
9 
10 occurs in approximately 1 in 200 people with diabetes, but can result from any cause 
11 
12 
of peripheral neuropathy (1,2). Despite its disabling impact on patients, it is often 
14 
15 overlooked, leading to a delay in diagnosis and subsequent mismanagement. A 
16 
17 timely diagnosis is key to the management of CN (3). Once a diagnosis is 
18 
19 established, initial treatment focuses on off-loading the affected limb to protect the 
20 
21 
22 skeleton until remission is achieved. 
23 
24 
25 
26 Simultaneous pancreas and kidney (SPK) transplantation is currently one of the 
27 
28 
management options for people with type 1 diabetes with end stage renal failure. 
30 
31 Results have shown patients have a better quality or life and longer life expectancy. 
32 
33 In individuals who may have had long standing poorly controlled diabetes, end organ 
34 
35 
complications may have occurred prior to SPK transplantation. However, after 
37 
38 transplantation eye, gut, nerve and vascular disease have been shown to stabilise or 
39 
40 improve as glycaemic control returns to the non-diabetic range (4). 
41 
42 
43 
44 
45 One diabetes related complication that does not usually improve, however, is 
46 
47 peripheral neuropathy. Charcot neuroarthopathy has been recognized to occur 
48 
49 following SPK transplantation, but usually within the first post-operative year (5-8). 
50 
51 
There are reports of CN occurring several years after SPK transplantation (9). We 
53 
54 present a case of bilateral simultaneous CN developing 11 years following SPK 
55 
56 transplantation in a patient with diabetes with pre-existing peripheral neuropathy. To 
57 
58 
59 
60 
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1 
2 
3 our knowledge, this is the first documentation of a bilateral Charcot late occurrence, 
4 
5 
after SPK transplantation. 
7 
8 
9 
10 Case Report 
11 
12 
A 55 year old self-employed builder had been diagnosed with type 1 diabetes 
14 
15 mellitus aged 15, and was managed with insulin until the age of 44. He had several 
16 
17 years of poor glycaemic control, and had developed proliferative diabetic retinopathy, 
18 
19 and end-stage renal failure. He had developed a dense bilateral peripheral 
20 
21 
22 neuropathy for which all other potential causes had been excluded. In particular, he 
23 
24 has no history of leprosy, spinal cord defects, syphilis, alcohol misuse, trauma, 
25 
26 amyloidosis, or other autoimmune conditions. His vitamin B12 concentrations were 
27 
28 
within the reference range. As a result, he underwent SPK transplantation. 
30 
31 
32 
33 Following transplantation, he was commenced on a regimen of corticosteroids and 
34 
35 
calcineurin inhibitors for immunosuppression. The operation resolved the need for 
37 
38 continued insulin therapy and reduced his blood glucose and glycated haemoglobin 
39 
40 (HbA1c) concentrations to the ‘non-diabetic’ ranges. Because he biochemically no 
41 
42 longer had diabetes, he was discharged from his local specialist diabetes services. 
43 
44 
45 
46 
47 Approximately 11 years later, the patient presented to his general practitioner with a 
48 
49 two-month history of increased temperature and swelling in his left foot. He was 
50 
51 
initially diagnosed with gout and commenced on treatment, which failed to resolve 
53 
54 his symptoms. Subsequently a radiograph was requested, which identified features 
55 
56 of a CN with midfoot fractures, consolidation and a loss of the medial longitudinal 
57 
58 
arch (Figures 1a and 1b). 
60 
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The overall duration of treatment was 4 months during which he was successfully 
7 
8 treated in a total contact cast until he was in remission followed by a below knee 
9 
10 removable walking boot. 
11 
12 
13 
14 
15 Unfortunately 1 month later, whilst under review he presented with features 
16 
17 consistent with a contralateral right CN. The diagnosis was confirmed by radiographs 
18 
19 (Figures 2a and 2b), and an MR scan (Figures 3a and 3b) of his right foot. 
20 
21 
22 
23 
24 Once a CN of the right foot was diagnosed, a similar management strategy ensued, 
25 
26 which was off-loading his affected foot. He is currently stable under regular review. 
27 
28 
29 
30 
31 Discussion 
32 
33 
34 
35 
We have described the unusual case of a man who presented with bilateral Charcot 
37 
38 neuroarthropathic feet 11 years after SPK transplantation. Prior to transplantation he 
39 
40 had poor control of his diabetes, and had evidence of end organ damage, including 
41 
42 dense bilateral peripheral neuropathy. The CN occurred despite him having glucose 
43 
44 
45 concentrations in the non-diabetic range following his SPK transplant. All other 
46 
47 causes of peripheral neuropathy had been excluded prior to his transplant and 
48 
49 subsequently, after he had developed his CN. 
50 
51 
52 
53 
54 Previous work has looked at CN following a SPK transplant (5-9). In two reviews, it 
55 
56 was reported that the development of a CN commonly occurred within the first year, 
57 
58 
with the latest occurrence at 5 years post transplantation (5,6). Whilst one previous 
60 
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1 
2 
3 case report has reported a case of CN 11 years after SPK transplantation (9), to our 
4 
5 
knowledge this is the first report detailing the development of bilateral CN a similar 
7 
8 time after an SPK transplant. 
9 
10 
11 
12 
We have previously described a similar case series of people developing CN after 
14 
15 attaining normoglycaemia after bariatric surgery (10). This patient was lost to follow 
16 
17 up when his SPK transplantation put his diabetes into remission and there was no 
18 
19 longer a need for dialysis. He did not receive regular foot care after that. His pre- 
20 
21 
22 existing peripheral neuropathy and subsequent use of calcineurin inhibitors used as 
23 
24 part of the immunosuppressive regimen may have also contributed because of the 
25 
26 direct effects on bone metabolism, or a directly neurotoxic effect (5,11). 
27 
28 
29 
30 
31 Barrado’s retrospective review of 100 patients identified 9 patients who developed a 
32 
33 CN (5). Almost half developed this within the first year, while the remaining 5 
34 
35 
developed the condition within the next 5 years. In their analysis, the authors state 
37 
38 that patients who developed a CN had a higher mortality and graft failure rate. They 
39 
40 identified that patients with high pre-transplant HbA1c values and use of high 
41 
42 corticosteroid doses as risk factors for developing an acute CN. 
43 
44 
45 
46 
47 Matricali et al’s, retrospective analysis of 66 patients, demonstrated a higher 
48 
49 incidence of development of CN at 12% (6). Their conclusions were similar to 
50 
51 
Barrado et al, with a high pre-transplant HbA1c as a significant risk factor for 
53 
54 developing a CN post SPK transplant and a higher rate of mortality and graft 
55 
56 rejection in the CN group. They also suggested their results were due to the small 
57 
58 
cohort of patients. 
60 
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In the review by Rangel et al, 130 patients without any history of CN were analysed 
7 
8 retrospectively (7). Six patients developed de novo CN during the first year. They 
9 
10 also suggested that high doses of glucocorticoids were the main risk factor leading to 
11 
12 
bone resorption and myofibril proteolysis. As a result of these reports and their own 2 
14 
15 cases, del Vecchio et al emphasized the importance of regular systematic follow up 
16 
17 of patients with diabetes undergoing SPK transplantation with a pre-existing 
18 
19 peripheral neuropathy (8). 
20 
21 
22 
23 
24 In summary, this is the second reported presentation of a CN occuring 11 years 
25 
26 following an SPK transplantation. However, our case is different to the one reported 
27 
28 
because it is bilateral. As this case demonstrates, there is no clear defined time 
30 
31 period beyond which we can assume a patient is not at risk of developing a de novo 
32 
33 CN following SPK transplantation. Therefore, despite normal glycaemic control 
34 
35 
following transplantation, these patients should remain under lifelong regular 
37 
38 specialist diabetes review. Patients and health care clinicians should maintain a high 
39 
40 degree of clinical suspicion when presented with a hot swollen foot with a concurrent 
41 
42 peripheral neuropathy. 
43 
44 
45 
46 
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3 Legends to Figures 
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5 
Figure 1a and 1b – Left foot AP and lateral radiograph demonstrating midfoot 
7 collapse, widening of the 1st and 2nd MT interspace. 
8 
9 
10 Figure 2a and 2b – Right foot AP and lateral radiograph demonstrating erosive 
11 arthopathic changes of the tarsometatarsal joints – in particular the first– with 
12 reduction in joint space and sclerosis (solid arrow). In addition, there are ununited 
13 fractures at the base of the third and fourth metatarsals (striped arrows). 
15 
16 
17 Figure 3a and 3b – Left foot MRI T1 sagittal and axial views demonstrating a 
18 destructive arthropathy of the common tarsometatarsal joint resulting in pes planus 
19 (solid arrow). There is marrow edema and severe erosive changes in the midfoot 
20 consistent with a Charcot neuroarthropathic joint. There is also collapse of the 
22 second metatarsal head. 
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26 Figure 1a and 1b – Left foot AP and lateral radiograph demonstrating midfoot collapse, widening of the 1st 
27 and 2nd MT interspace. 
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Figure 3a and 3b – Left foot MRI T1 sagittal and axial views demonstrating a destructive arthropathy of the 
19 
common tarsometatarsal joint resulting in pes planus (solid arrow). There is marrow edema and severe 20 
erosive changes in the midfoot consistent with a Charcot neuroarthropathic joint. There is also collapse of 21 
the second metatarsal head.” 
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